CRLM in the Era of Transplant Oncology: New Hope, New Questions
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 15
Special Issue Editors
Interests: pathogenesis of HPB cancers; surgical innovation; organ preservation; machine perfusion; US histotripsy; irreversible electroporation (IRE); evidence based healthcare
Special Issues, Collections and Topics in MDPI journals
Interests: colorectal cancer; anal cancer; bile duct cancer (cholangiocarcinoma); biliary cancer; cancer of unknown primary; colon cancer; gastrointestinal cancers; medical oncology; small bowel cancer liquid biopsies; tumour heterogeneity; patient derived organoids; bioinformatics; next generation sequencing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Colorectal liver metastases (CRLM) remain one of the most challenging domains in oncologic surgery, with curative resection only available to a minority of patients. However, recent data, most notably from the TRANSMET study have brought new optimism. The demonstration of a survival benefit in selected patients with unresectable CRLM undergoing liver transplantation marks a potential paradigm shift in treatment strategy.
This emerging therapeutic avenue raises several pressing clinical and scientific questions. Should adjuvant or maintenance chemotherapy be continued post-transplant? Could liquid biopsy or circulating tumor DNA (ctDNA) be leveraged for surveillance or patient selection? What are the ethical, logistical, and immunological considerations when transplanting patients with active malignancy?
Given this rapidly evolving landscape, we propose a Special Issue dedicated to CRLM, with a focus on cutting-edge developments in transplantation, systemic therapy, molecular stratification, and post-treatment surveillance. The goal is to bring together surgical oncologists, hepatologists, transplant teams, medical oncologists, and molecular biologists to chart the future of CRLM management.
Prof. Dr. Brian Davidson
Dr. Khurum Khan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colorectal cancer
- liver transplant
- transplant oncology
- chemotherapy
- immunotherapy
- immunosuppression
- genetic profiling
- circulating ccDNA
- staging
- surveillance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
